Avigilon Slashes Elevated Temperature Detection Pricing

Published Nov 25, 2020 13:51 PM

Avigilon has now slashed the prices of its temperature screening product by more than 50% with its second price in the past few months.

IPVM Image

Earlier this year, the fever camera market boomed but more recently, it is beginning to bust (e.g., FLIR and Dali results).

For background, see Avigilon Elevated Temperature Detection Camera Tested.

In this note, we review these cuts, Avigilon's feedback, and the future of the 'fever camera' market.

Price *** ********

**** ** ******* **** ** $**,*** for *** ****** *** ********* ***, Avigilon's *** *** *** *** ******* to **** $*,***:

IPVM Image

Avigilon ********

******** ***** ********* ******, ********** ** IPVM:

** *** ******** * *********** ******** on *** ** *** ****** ** we ******* ****** *** ****** *** inventory ******.

**** *****, **** ** $*,*** ****, they ******* **** *** ******** **********:

** ***** ** **** *****, *** given *** *********** ** *** ********, that **’** *** **** ***** ** the ******.

Big ******* **********

**** ***** **** *** ****** ******** from ******** *** *** ****** *** video ************ ************, **** *****.

*******, *** ******* ** '*****' ******** have **** **** **** **** ****. As ** ******** ** ***** *** Hikvision's ** ***** ****** ****** ******** ****** ***********, ******* ** ***% **** ****** ordinary.

********'* *******, ** $*,*** ****, *** less ***** ** **, ********** ***** they *** * **** ********* *** x *** ******* ******, *** ****** than ********* *** ***********. ** *** other ****, ******** **** * ********** low-cost *********** ********* ***** ******* ***** cost *********.

Best ***** - ********?

** $*,*** ****, *** ***** ** certainly ********* *** ** ** **** than **** *****, *********, *** ********* all ***** ****** ********* *******. **** noted, ** ******* ***** *** ********* could ****** ***** ***** ****** ******* to ******** *** ***** **** **** profits.

*** **** ******* ***-**** ****** ** the**** **** - * ~$*,*** ******** including * ********* (*** **** **** results).

** ******, *** ******* ********** ** any ***** '******' ******** ** *** fever *******. ***** ******* *** ***** sold ** ~$*,***, ***** **** **** expensive **** ******** **** ***** *** price ****. *******, *** ******* ******** ***** ******* ** ** ********* rigged, ************** ************** ******** ************ *** thereby ********** *** **** ** ******* fevers.

Sales *******

*** *** ***********, ********* ********, ** is ******** **** * ********* ****** surge *********** ********* ******, *** **** many ******** ********* ** ***** ******* up ********** ************ ** *** **** few ******, *** *** ** *** fever ****** **** ** ***** ** hand.

Comments (12)
UM
Undisclosed Manufacturer #1
Nov 28, 2020

**********: * **** *** * **********.

*** *** ***** **** ***** ******* me (** ** **********) ** * customer ****** *** **** ****** *** built **** **** ******* **** *** could **** ******** ** **** *************. I ***** **** *** ****** ***** on *** ****** *** *** ****** to **** *** ***** ***** ***** to ****** *****.

*'** ** ********** ** **** ***** comments *** ********.

(2)
(1)
JH
John Honovich
Nov 28, 2020
IPVM

**** **** * **** ***** **** various *******, *** ***** ***** ******* (excluding *********) **** **** **** $*,*** and *** ***** **** *** $*,*** to $*,***.

* ** *** **** **** ********'* cost ********* **, ********* ******, *** I *******, ** ***, **** **** are ***** ****** *****.

(1)
UI
Undisclosed Integrator #2
Nov 29, 2020

***** ***. ***** **** * ******** without * ******.

(2)
UI
Undisclosed Integrator #3
Nov 30, 2020

** ************* ** **** **** *** not ***** ** ** *** **** approval ** * ****** *** **** effects *** ****** ** *********** *** will **** ****. * **** ** at ***** *** **** **** ** a ******** ***** ***.

(3)
JI
Jordi Ibero
Dec 01, 2020
Imago IP Solutions

*** **** *** **?

JH
John Honovich
Dec 01, 2020
IPVM

**** *** *** ***** ** ** for **** ********

*'** ***** ******** *** * ******** on ****.

Avatar
Jeremiah Main
Dec 01, 2020
IPVMU Certified

* ***'* **** * ******* **** hasn't ** ***** ******* *** **.

(2)
(1)
JH
John Honovich
Dec 01, 2020
IPVM

** **** ***** *** *** *** have *** ***** *** *** ** verify **** **** ******* ******* *** applied. * ******* *** ** ****** as ** ************ ** *** *** directory *** **** **** *** **** they **** *******.

(1)
JH
John Honovich
Dec 03, 2020
IPVM

******** ******** *** ******** *** ******** to ****** ***(*):

** ******** ** ******* *** ** ETD ******** ***** *** ***** ******** Enforcement ****** *** ************* ******* *** have **** ******* ** ****** ***** guidelines **********. ****** ***** ** * change ** *** ****** ****** *** such ********* ** ***'* **** ** proceed **** ***(*) *************.

(2)
Avatar
Jeremiah Main
Dec 04, 2020
IPVMU Certified

****'* *** **** *** **** ***** we ****** ** * ***** ** emergency *** *** *** ** ********** enforcement. ** ******** ** **** ******* after *** ***** ** ********* ** lifted? **** *** ******** **** ** stop ***** ** ** **** *********** from *** *** ** ** *********** only ****** ****** *** ************? **** about *** ********** *** **** **? Even ** *** *** ***'* ******* things **** *** ****, *'* **** a ****** ***** ***** ** ** that ** * ********* ** ********** suit ******* * **** ********* ** un-certified ****** ** **** ************, *******?

JH
John Honovich
Dec 04, 2020
IPVM

**** *** ******** **** ** **** using ** ** **** *********** **** the *** ** ** *********** **** geared ****** *** ************?

******* *** **** ********** **** *** *** "**** *** intend ** ****** ** *** ************ and ***... ***** **** ******* ** not ****** ** ***** ****." **** that *****, **** ***** '******' ** actually '******' ** **** ***.

*** ******** ** ******* ****** **** still ** ***** **** ***** *** FDA ******* *** ******** ****. *** FDA ***** ****** **** **** ***** or ***** *** *** *****, * don't ***** ****** ***** *** ****.

* *** ** **** *** ******* of ***** ******* ****** **** ** be ******* ** **** ** *****-** goes ****.

(1)
UI
Undisclosed Integrator #3
Dec 04, 2020

***, ***** ** *** ****** *** at ***** *** ******** ********** ***'* sell *********** ******** **** **** *** FDA's ******* ********** ** ***********.

(1)